2022 MIT Technology Review’s EmTech: Flagship Founder & CEO Noubar Afeyan on Programmable Medicines

Video: MIT Technology Review’s EmTech MIT Conference
Flagship Founder & CEO Noubar Afeyan gives a talk about programmable medicines at EmTech 2022, MIT Technology Review’s annual gathering on emerging technology and global trends.
About Flagship Pioneering:
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises over 40 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, Moderna , Omega Therapeutics, Sana Biotechnology, Seres Therapeutics, and Tessera Therapeutics.
Website: www.flagshipioneering.com
Linkedin: www.linkedin.com/company/flagship-pioneering
Twitter: @FlagshipPioneer